Showing 18,581 - 18,600 results of 19,405 for search '(( 59 ((0 decrease) OR (a decrease)) ) OR ( 50 ((we decrease) OR (nn decrease)) ))', query time: 0.89s Refine Results
  1. 18581

    Image_1_Trends in Disease Burden Attributable to Tobacco in China, 1990–2017: Findings From the Global Burden of Disease Study 2017.JPEG by Haoyu Wen (4961833)

    Published 2020
    “…From 1990 to 2017, the tobacco-attributable death rates per 100,000 people decreased from 75.65 [95% uncertainty interval (95% UI) = 56.23–97.74] to 70.90 (95% UI = 59.67–83.72) in females and increased from 198.83 (95% UI = 181.39–217.47) to 292.39 (95% UI = 271.28–313.76) in males. …”
  2. 18582

    Table_1_Trends in Disease Burden Attributable to Tobacco in China, 1990–2017: Findings From the Global Burden of Disease Study 2017.DOCX by Haoyu Wen (4961833)

    Published 2020
    “…From 1990 to 2017, the tobacco-attributable death rates per 100,000 people decreased from 75.65 [95% uncertainty interval (95% UI) = 56.23–97.74] to 70.90 (95% UI = 59.67–83.72) in females and increased from 198.83 (95% UI = 181.39–217.47) to 292.39 (95% UI = 271.28–313.76) in males. …”
  3. 18583

    Image_1_Trends in Disease Burden Attributable to Tobacco in China, 1990–2017: Findings From the Global Burden of Disease Study 2017.JPEG by Haoyu Wen (4961833)

    Published 2020
    “…From 1990 to 2017, the tobacco-attributable death rates per 100,000 people decreased from 75.65 [95% uncertainty interval (95% UI) = 56.23–97.74] to 70.90 (95% UI = 59.67–83.72) in females and increased from 198.83 (95% UI = 181.39–217.47) to 292.39 (95% UI = 271.28–313.76) in males. …”
  4. 18584

    Image_2_Trends in Disease Burden Attributable to Tobacco in China, 1990–2017: Findings From the Global Burden of Disease Study 2017.JPEG by Haoyu Wen (4961833)

    Published 2020
    “…From 1990 to 2017, the tobacco-attributable death rates per 100,000 people decreased from 75.65 [95% uncertainty interval (95% UI) = 56.23–97.74] to 70.90 (95% UI = 59.67–83.72) in females and increased from 198.83 (95% UI = 181.39–217.47) to 292.39 (95% UI = 271.28–313.76) in males. …”
  5. 18585

    Image_2_Trends in Disease Burden Attributable to Tobacco in China, 1990–2017: Findings From the Global Burden of Disease Study 2017.JPEG by Haoyu Wen (4961833)

    Published 2020
    “…From 1990 to 2017, the tobacco-attributable death rates per 100,000 people decreased from 75.65 [95% uncertainty interval (95% UI) = 56.23–97.74] to 70.90 (95% UI = 59.67–83.72) in females and increased from 198.83 (95% UI = 181.39–217.47) to 292.39 (95% UI = 271.28–313.76) in males. …”
  6. 18586

    Table_1_Trends in Disease Burden Attributable to Tobacco in China, 1990–2017: Findings From the Global Burden of Disease Study 2017.DOCX by Haoyu Wen (4961833)

    Published 2020
    “…From 1990 to 2017, the tobacco-attributable death rates per 100,000 people decreased from 75.65 [95% uncertainty interval (95% UI) = 56.23–97.74] to 70.90 (95% UI = 59.67–83.72) in females and increased from 198.83 (95% UI = 181.39–217.47) to 292.39 (95% UI = 271.28–313.76) in males. …”
  7. 18587

    SPIRIT schedule of assessments. by Colin E. Swenson (20727113)

    Published 2025
    “…ETI is currently prescribed solely for treatment of CF and has not been adequately tested or proposed for patients with NCFBE, many of whom exhibit decreased CFTR function. Accordingly, we are conducting a clinical trial of ETI in subjects carrying a diagnosis of NCFBE.…”
  8. 18588

    Summary of study design. by Colin E. Swenson (20727113)

    Published 2025
    “…ETI is currently prescribed solely for treatment of CF and has not been adequately tested or proposed for patients with NCFBE, many of whom exhibit decreased CFTR function. Accordingly, we are conducting a clinical trial of ETI in subjects carrying a diagnosis of NCFBE.…”
  9. 18589

    Conformationally mobile acyclic cucurbit[n]uril-type receptors derived from an S-shaped methylene bridged glycoluril pentamer by Kimberly G. Brady (9277178)

    Published 2020
    “…This energetically unfavourable conformer selection results in significantly decreased K<sub>a</sub> values of <b>P1</b> and <b>P2</b> compared to <b>Tet1</b> and <b>Tet2</b>.…”
  10. 18590

    Table_1_Effect of progesterone concentration on hCG trigger day on clinical outcomes after high-quality single blastocyst transfer in GnRH antagonist cycles.docx by Nan Jia (118883)

    Published 2024
    “…</p>Results<p>When progesterone levels were between 1 and 2 ng/ml, the pregnancy rate in fresh cycles was only 51% of that in cycles with progesterone levels ≤1 ng/ml (95% CI: 0.33, 0.79, p = 0.0028). And the pregnancy rate decreased by 25% (95% CI: 0.51, 1.09) for frozen cycles, although there was no statistically significant (p = 0.1273). …”
  11. 18591

    Table_1_Effect of progesterone concentration on hCG trigger day on clinical outcomes after high-quality single blastocyst transfer in GnRH antagonist cycles.docx by Nan Jia (118883)

    Published 2024
    “…</p>Results<p>When progesterone levels were between 1 and 2 ng/ml, the pregnancy rate in fresh cycles was only 51% of that in cycles with progesterone levels ≤1 ng/ml (95% CI: 0.33, 0.79, p = 0.0028). And the pregnancy rate decreased by 25% (95% CI: 0.51, 1.09) for frozen cycles, although there was no statistically significant (p = 0.1273). …”
  12. 18592

    The increase of NR2B-mediated NMDARs Ca<sup>2+</sup> responses induced by BFA is rescued by reelin. by Cecilia Gonzalez Campo (264260)

    Published 2009
    “…Bar graph representing average percentage of NMDA-induced Ca<sup>2+</sup> influx remaining after ifenprodil application during maturation. Values were 57.0±10.0% at 6 div, 56.5±6.8% at 7 div, and 59.0±6.6% of control response at 8 div. …”
  13. 18593

    Table1_Aspirin intervention before ICU admission reduced the mortality in critically ill patients with acute kidney injury: results from the MIMIC-IV.docx by Yao Meng (594490)

    Published 2023
    “…In multivariate models, we found a decreased risk of mortality in those who received aspirin before ICU compared to those who did not (30-day:hazard ratio [HR], 0.70; 95% CI, 0.62–0.79; p < 0.001; 90-day:HR, 0.70; 95% CI, 0.63–0.77, p < 0.001; 180-day:HR, 0.72; 95%CI,0.65–0.79, p < 0.001). …”
  14. 18594

    datasheet1_Spatio-Temporal Variability of Peat CH4 and N2O Fluxes and Their Contribution to Peat GHG Budgets in Indonesian Forests and Oil Palm Plantations.docx by Erin Swails (10323518)

    Published 2021
    “…N<sub>2</sub>O emissions (kg N<sub>2</sub>O ha<sup>−1</sup> year<sup>−1</sup>) were highly variable spatially and temporally and similar across land-uses (5.0 ± 3.9 and 5.2 ± 3.7 in oil palm and forest). …”
  15. 18595

    Supplementary Material for: Words versus strands: Reliability and stability of concordance rates of self-reported and hair-analyzed substance use of young adults over time by Janousch C. (19792158)

    Published 2024
    “…At the first time point, the sample with self-report and hair analysis comprised 1,002 participants (Mage=20.6 (SD=0.38) yrs., 50.2% female), of which 761 (Mage=24.5 (SD=0.38) yrs., 48.3% female) also provided hair at the second time point. …”
  16. 18596

    Bacterial strains used in this study. by Nobuo Fuke (22190368)

    Published 2025
    “…<i><i>elegans</i></i>. We cultured <i><i>Escherichia coli</i></i> OP50 (the standard <i><i>C</i></i>. …”
  17. 18597

    Table_1_Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis.DOCX by Mariapaola Marino (784475)

    Published 2020
    “…In patients’ sera, we titrated MuSK-specific IgG (MuSK-IgG) and MuSK-IgG4, along with total IgG and IgG4 levels. …”
  18. 18598

    Image_1_Cellular and Humoral Immune Responses and Breakthrough Infections After Two Doses of BNT162b Vaccine in Healthcare Workers (HW) 180 Days After the Second Vaccine Dose.TIFF by Alessandra Mangia (626370)

    Published 2022
    “…Following the predictive model of protection by Khoury, we transformed the neutralizing titers in IU/ml and used a 54 IU/ml threshold to identify subjects with 50% protective immunity. …”
  19. 18599

    Table 2_Discussion on the duration of response following HBsAg clearance in patients with chronic hepatitis B treated with PegIFNα-2b.docx by Tao Wang (12008)

    Published 2025
    “…Among these 26 patients, 50% (13/26) experienced reversion within 24 weeks, and 80.77% within 48 weeks; thereafter, the number of reversions gradually decreased. …”
  20. 18600

    Image_2_Cellular and Humoral Immune Responses and Breakthrough Infections After Two Doses of BNT162b Vaccine in Healthcare Workers (HW) 180 Days After the Second Vaccine Dose.TIFF by Alessandra Mangia (626370)

    Published 2022
    “…Following the predictive model of protection by Khoury, we transformed the neutralizing titers in IU/ml and used a 54 IU/ml threshold to identify subjects with 50% protective immunity. …”